Polysciences, Inc. is established
Founded by B. David Halpern to supply ultrapure reagents for the electron microscopy market, establishing a scientific foundation that would shape the company for decades to come.
⟡ Our Story / Since 1961 / Warrington, Pennsylvania
Since 1961, Polysciences has grown from a company serving highly specialized scientific needs into a broader specialty chemistry platform supporting research, diagnostics, advanced materials, and manufacturing-oriented applications. The timeline below reflects the milestones that shaped that evolution over time, and the stewardship-driven approach that continues to guide the company today.
Timeline
From founding and early catalog expansion to acquisitions, certifications, bioprocessing growth, and new lab capabilities, these milestones show how Polysciences developed over time through scientific rigor, operational expansion, and steady long-term investment.
Founded by B. David Halpern to supply ultrapure reagents for the electron microscopy market, establishing a scientific foundation that would shape the company for decades to come.
Polysciences publishes a catalog including Polymer Research, Life Sciences, Electron Microscopy, and Biomedical Applications sections, reflecting a broader and more interdisciplinary technical portfolio.
Polysciences develops a large-scale process for isolating taxol, now used in treating solid tumor cancers, underscoring the company’s applied scientific depth.
Michael Ott purchases Polysciences and establishes Polysciences Europe, GmbH, expanding the supply of specialized chemicals in Europe and beginning a family-ownership chapter centered on stewardship, long-term investment, and enduring customer relationships.
The portfolio grows through the acquisition of Bangs Laboratories, Inc. (microsphere-based reagents and diagnostics), Dream Cosmetics (private-label cosmetics), and Dionis (consumer products), broadening the company’s reach while preserving technical specialization.
As part of its broader Asia-Pacific expansion, Polysciences opened its Taipei office in 2011, extending regional support and strengthening the company’s international footprint.
Polysciences achieves ISO 13485 Quality Management Certification, in addition to being FDA approved and SOCMA recognized.
View certificateExpands the commercial bioprocessing catalog, adds cleanroom space for production and packaging, establishes dedicated production suites for GMP and non-GMP custom synthesis projects, and forms Ott Scientific as the parent organization.
Polysciences celebrates 60 years of innovation, unifies legacy brands under Ethos Biosciences, and expands globally with the establishment of Ott Scientific Brasil and Ott Scientific India.
Finalizes buildout of an advanced analytical lab and “The Exchange,” a modern breakroom for collaboration and employee engagement, representing an investment in both technical capability and the people behind it.
Opens an expansive Quality Control lab, enhancing product testing, and launches Kyfora Bio, which is established as a standalone LLC in April 2024 to advance bioprocessing solutions for biopharma and biotech industries.
Polysciences is recognized as a SOCMA ChemStewards Safety Champion, completes a new lab suite buildout, and introduces a BSL-2 biolab, significantly enhancing research, development, and safety capabilities.
Today, Polysciences continues to operate with a long-view mindset—investing thoughtfully in people, facilities, quality systems, and interdisciplinary capabilities so it can remain a dependable partner in an increasingly complex technical landscape.
Legacy in view
The growth of Polysciences is reflected not only in dates and milestones, but also in the facilities, labs, and operating environments built to support more advanced work over time.
Explore more of Polysciences
FAQ
Click a question to expand.
Continue from the company’s history into the broader overview of its current products, services, operating model, and long-term customer partnerships.